Congratulations! Haibu Pharmaceutical has been listed on the most influential list in the Chinese pharmaceutical industry for three consecutive years.

The "2020 13th China Pharmaceutical Industry Development Summit Forum and 2019 Annual China Pharmaceutical Industry Most Influential List Release Conference", hosted by the All-China Federation of Industry and Commerce Pharmaceutical Industry Chamber of Commerce and the Ganjiang New District Management Committee, and organized by the China (Nanchang) Traditional Chinese Medicine Science and Technology Innovation City Management Committee, was grandly held in Nanchang from August 6 to 8, 2020.

The release conference for the most influential list in the Chinese pharmaceutical industry, hosted by the All-China Federation of Industry and Commerce Pharmaceutical Industry Chamber of Commerce, has been held for seven consecutive sessions and has become an annual brand event in China's pharmaceutical industry. This year's list release conference announced ten lists including the top 100 Chinese pharmaceutical companies and the top 20 Chinese pharmaceutical R&D companies for 2019.

This forum gathered many prominent figures, including Wu Zhongqiong, Vice Governor of Jiangxi Province; Li Zhaoqian, Vice Chairman of the All-China Federation of Industry and Commerce; renowned economist and special researcher at the State Council Research Office Yao Jingyuan; Xiu Laigui, President of the All-China Federation of Industry and Commerce Pharmaceutical Industry Chamber of Commerce and Chairman of Xiu Zheng Pharmaceutical Group. They participated in this meeting and delivered important speeches. The discussions focused on macroeconomic trends in the post-pandemic era, current developments in the pharmaceutical industry, and enhancing corporate cooperation for mutual benefit. They collectively analyzed the current state of development in the pharmaceutical industry, addressed industry pain points, and provided direction on how China's pharmaceutical industry can seize opportunities and innovate.

With a work spirit of "professionalism, dedication, focus", Haibu Pharmaceutical continues to provide customers with first-class quality services across multiple modules throughout the entire process—from raw materials to formulations, project evaluation, laboratory R&D, process transfer production to clinical trials and drug registration. At this summit, it was once again awarded as one of China's top 20 pharmaceutical R&D companies on the most influential list for 2019.

Seizing historical opportunities to forge a healthy future together, Haibu Pharmaceutical will continue to uphold its philosophy of "integrity, professionalism, cooperation, mutual benefit". Through scientific rigorous efficient R&D work, it aims to promote drug market entry processes that bring happiness to people's lives and hope to life.